Who We Serve

Post-Approval Studies & Registries

Once a drug or device achieves regulatory approval, the need for research doesn't end. In fact, it gets more demanding as the number of participants increases and the objectives change. Clinipace is focused on the unique needs of post-marketing studies, and offers a proven clinical research platform to build and manage optimized studies capable of reaching thousands of investigators around the globe.

With Clinipace, investigators can capture data and deliver real-time information to stakeholders and sponsors to make real-time decisions. Our TEMPO platform is designed specifically to meet the unique demands of Phase IV studies, registries and investigator initiated studies.

Go Forward with TEMPO

Easy to use, flexible in design to meet unique study demands and highly scalable, TEMPO is designed to deliver substantial value to investigator sites as well as the sponsors.

Did You Know?

TEMPO supported one of the largest web-based Phase IV studies ever conducted:

  • Patients: 22,000+
  • Investigators: 850+
  • Countries: 14

© CLINIPACE. ALL RIGHTS RESERVED